Corticosteriod Tapering in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Subcutaneous Daratumumab (DARA SC): Part 3 of the Open-Label, Multicenter, Phase Ib PAVO Study.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要